相关实验视频

Updated: Jun 23, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

皮肤穿透冠状动脉干预后的脂蛋白和长期静脉静脉缩

Ahmed K Mahmoud¹, Juan M Farina¹, Kamal Awad¹

¹Department of Cardiovascular Medicine, Mayo Clinic, 5777 E Mayo Blvd, Phoenix, AZ 85054, USA.

European journal of preventive cardiology

|June 25, 2024

概括

高脂蛋白 (Lp) 水平与皮肤穿透冠状动脉干预 (PCI) 后静脉静脉缩 (ISR) 的风险增加有关. Lp (a) 是长期ISR的独立预测指标,指导PCI后的患者评估.

科学领域:

心脏病学心脏病学
生物化学生物化学
医学研究医学研究

背景情况:

脂蛋白 (Lp) 与动脉样硬化和心肌梗塞有关.
在穿皮冠状动脉干预 (PCI) 后,Lp (a) 在静脉静脉阻滞 (ISR) 中的作用需要进一步澄清.

研究的目的:

调查Lp (a) 水平与PCI后ISR的发展之间的关联.

主要方法:

对1209名经过成功PCI的成年患者进行了回顾性研究.
患者分为高Lp (≥50 mg/dL) 和低Lp (<50 mg/dL) 的两组.
单变量和多变量分析以评估ISR风险.

主要成果:

在13.4%的患者中观察到ISR.
在ISR患者 (27毫克/分升) 和非ISR患者 (20毫克/分升) 中,中位数Lp (a) 水平较高.
高Lp (a) 组显示显著更高的ISR率 (17.0%对11.6%) 并与ISR事件独立相关 (HR 1.67).

结论:

脂蛋白 (a) 是长期ISR的独立预测因素.
在评估接受PCI的患者时,应考虑Lp (a) 水平.

关键词:

冠状动脉疾病是一种冠状动脉疾病.实体静脉复缩 (英语:In-stent restenosis) 是一种体内静脉复缩.脂蛋白 (a) 是一种蛋白质心肌梗塞的心脏病发作通过皮肤进行冠状动脉干预.

更多相关视频

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...